Novel complication of nusinersen treatment: Hyponatremia

Creative Commons License

Coban Y., Aslan N., Yildizdas D., ÖZGÜR HOROZ Ö., GÜL MERT G.

NEUROLOGY ASIA, vol.25, no.1, pp.85-86, 2020 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 25 Issue: 1
  • Publication Date: 2020
  • Doi Number: 10.29328/journal.jcicm.1001014
  • Journal Name: NEUROLOGY ASIA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE
  • Page Numbers: pp.85-86
  • Çukurova University Affiliated: Yes

Abstract

Nusinersen is a novel therapy for spinal muscular atrophy (SMA) type 1. Thus, the adverse reactions of the therapy have not been well established. We present here a 5-months old boy with SMA type 1, who developed hyponatremia after a single dose of nursinersen which has been rarely reported previously.